Why novartis Is Trending Today?

Avidity Biosciences is in the spotlight today, with Novartis announcing a $12 billion cash deal to acquire the biotech company, sending Avidity's stock soaring. The acquisition aims to expand Novartis' neuroscience portfolio. Meanwhile, David Eby, British Columbia's Attorney General, confirms that the province's anti-tariff ads targeting Americans will proceed. In the music world, Lily Allen's new album, seemingly detailing her divorce from David Harbour, has sparked interest, with fans eager to learn more about their relationship timeline. Additionally, David Lammy, the UK's Justice Secretary, faces questions in the Commons after the arrest of a migrant sex offender who was mistakenly freed from jail.

Novartis, a leading Swiss drugmaker, has agreed to acquire Avidity Biosciences, a US-based biotech firm specializing in RNA therapies for rare diseases, in a deal valued at approximately $12 billion. The acquisition, which is expected to boost Novartis' pipeline in rare diseases, involves Novartis paying around $70 per share for Avidity Biosciences.